Drugdiscovery >> Drugs >> News
3118
Views
title
Combining tofacitinib with DMARDs beneficial for patients with active rheumatoid arthritis - drugdiscovery.com


According to a recent study, tofacitinib, in addition to disease-modifying anti-rheumatic drugs (DMARDs),showed safe and effective in improving symptoms in patients with active rheumatoid arthritis (RA).
Read More >>


Tags: rheumatoid arthritis, tofacitinib, Janus kinase inhibitor, anti-rheumatic drugs - August 20, 2013
Related Articles
4322
Views
Best-selling rheumatoid arthritis drugs in 2013 Best-selling rheumatoid arthritis drugs in 2013
The anti-rheumatics market is currently the second largest treatment area in the world by sales. See a top 10 list of RA drugs in 2013 and the forecast for this market in the future. Read More >>

Tags: Best-selling, rheumatoid arthritis, drugs, 2013, top 10

4722
Views
Antares’ methotrexate injection approved by FDA Antares’ methotrexate injection approved by FDA
Antares Pharma’s new methotrexate delivery system-Otrexup injection is the first FDA approved subcutaneous methotrexate, indicated for the treatment of severe active rheumatoid arthritis and severe Read More >>

Tags: Antares, methotrexate, injection, Otrexup, FDA, rheumatoid arthritis, subcutaneous

4119
Views
Statins beneficial  for  severe asthma patients  Statins beneficial for severe asthma patients
The addition of statins to their inhaler therapy could significantly improve asthma control in patients suffering from severe asthma, according to a new study. Read More >>

Tags: statins, asthma, benefit, therapy

4914
Views
 Afatinib  is beneficial  for patients with distinct subtype of lung cancer Afatinib is beneficial for patients with distinct subtype of lung cancer
The results of LUX-Lung phase III trial show that Afatinib delays tumour growth and improves disease-related symptoms in patients with EGFR mutation positive, advanced non-small cell lung cancer (NSC Read More >>

Tags: Afatinib, lung cancer, EGFR mutation

5634
Views
Orencia: indications, interactions, side effects and warnings Orencia: indications, interactions, side effects and warnings
Orencia (abatacept) is a selective co-stimulation modulator which inhibits the costimulation of T cells. It is used to treat the symptoms of rheumatoid arthritis in the case of inadequate response to Read More >>

Tags: Orencia, abatacept, rheumatoid arthritis, indications, interactions, side effects, warnings

5588
Views
Femara beneficial for breast cancer patients treated with tamoxifen Femara beneficial for breast cancer patients treated with tamoxifen
The results of a large study show that femara significantly reduces the risk of breast cancer reccurence in patients who were treated both drugs. Read More >>

Tags: breast cancer, femara, tamoxifen, risk, recurrence

3904
Views
FDA approves Cimzia for the treatment of psoriatic arthritis FDA approves Cimzia for the treatment of psoriatic arthritis
After a successful Phase 3 trial, Cimzia (certolizumab pegol) is now approved for the treatment of psoriatic arthritis. The drug is already being used in the US for the treatment of rheumatoid arthrit Read More >>

Tags: Cimzia, psoriatic arthritis, certolizumab pegol, FDA

3254
Views
Stelara approved in US and EU for psoriatic arthritis Stelara approved in US and EU for psoriatic arthritis
Stelara (ustekinumab), a human interleukin (IL)-12 and IL-23 antagonist, is approved to be used alone or in combination with methotrexate for the treatment of adult patients with active psoriatic arth Read More >>

Tags: Stelara, ustekinumab, interleukin 12, interleukin 23, antagonist, psoriatic arthritis, FDA, US, EU

12524
Views
Teva’s drug for treating neutropenia approved in EU Teva’s drug for treating neutropenia approved in EU
Teva got EU market authorization for the drug Lonquex (lipegfilgrastim) , which is used for reduction of the duration of neutropenia and the incidence of febrile neutropenia in patients undergoing c Read More >>

Tags: Teva, lonquex, Neulasta, EMA, EU, approval,febrile neutropenia, neutropenia, cancer patients, patients undergoing chemotherapy

4703
Views
Preventive Isoniazid therapy beneficial for HIV-infected people Preventive Isoniazid therapy beneficial for HIV-infected people
A large international study revealed that preventive antibiotic therapy in people with HIV lowers their risk of developing tuberculosis and dying of it. Read More >>

Tags: HIV, Isoniazid, tuberculosis, risk, antibiotic

MOST VIEWED
HOME | ABOUT | PRIVACY POLICY | TERMS & CONDITIONS | ADVERTISE | CONTACT
All rights reserved drugdiscovery.com 2013